JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB133090

Cytosolic Phospholipase A2 Assay Kit

Be the first to review this product! Submit a review

|

(20 Publications)

Cytosolic Phospholipase A2 Assay Kit (ab133090) can be used to determine the activity of cytosolic Phospholipase A2 (cPLA2) in purified preparations, cell cultures, or tissue homogenates.

View Alternative Names

CPLA2, PLA2G4, PLA2G4A, Cytosolic phospholipase A2, cPLA2, Phospholipase A2 group IVA

Key facts

Detection method

Colorimetric

Sample types

Cell culture extracts, Tissue Extracts

Assay type

Enzyme activity (quantitative)

Assay Platform

Microplate reader

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "Enzyme activity assay": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Product details

Cytosolic Phospholipase A2 Assay Kit (ab133090) can be used to determine the activity of cytosolic Phospholipase A2 (cPLA2) in purified preparations, cell cultures, or tissue homogenates. Use of this assay with preparations containing more than one type of PLA2 will result in the measurement of total PLA2 activity rather than cPLA2 alone.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

What's included?

{ "values": { "96Test": { "sellingSize": "96 Test", "publicAssetCode":"ab133090-96Test", "assetComponentDetails": [ { "size":"1 x 1 Unit", "name":"96-Well Plate Cover", "number":"AB133090-CMP02", "productcode":"" }, { "size":"1 x 1 Unit", "name":"96-Well Plate (Colorimetric Assay)", "number":"AB133090-CMP01", "productcode":"" }, { "size":"2 x 1 Vial", "name":"Arachidonoyl Thio-PC (Substrate)", "number":"AB133090-CMP03", "productcode":"" }, { "size":"1 x 1 Vial", "name":"Bromoenol Lactone Solution", "number":"AB133090-CMP05", "productcode":"" }, { "size":"4 x 1 Vial", "name":"DTNB/EGTA", "number":"AB133090-CMP07", "productcode":"" }, { "size":"1 x 1 Vial", "name":"cPLA2 Assay Buffer", "number":"AB133090-CMP06", "productcode":"" }, { "size":"1 x 1 Vial", "name":"Bee venom PLA2 Control", "number":"AB133090-CMP04", "productcode":"" } ] } } }

Properties and storage information

Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
Multi
Storage information
-20°C

Product protocols

Target data

Has primarily calcium-dependent phospholipase and lysophospholipase activities, with a major role in membrane lipid remodeling and biosynthesis of lipid mediators of the inflammatory response (PubMed : 10358058, PubMed : 14709560, PubMed : 16617059, PubMed : 17472963, PubMed : 18451993, PubMed : 27642067, PubMed : 7794891, PubMed : 8619991, PubMed : 8702602, PubMed : 9425121). Plays an important role in embryo implantation and parturition through its ability to trigger prostanoid production (By similarity). Preferentially hydrolyzes the ester bond of the fatty acyl group attached at sn-2 position of phospholipids (phospholipase A2 activity) (PubMed : 10358058, PubMed : 17472963, PubMed : 18451993, PubMed : 7794891, PubMed : 8619991, PubMed : 9425121). Selectively hydrolyzes sn-2 arachidonoyl group from membrane phospholipids, providing the precursor for eicosanoid biosynthesis via the cyclooxygenase pathway (PubMed : 10358058, PubMed : 17472963, PubMed : 18451993, PubMed : 7794891, PubMed : 9425121). In an alternative pathway of eicosanoid biosynthesis, hydrolyzes sn-2 fatty acyl chain of eicosanoid lysophopholipids to release free bioactive eicosanoids (PubMed : 27642067). Hydrolyzes the ester bond of the fatty acyl group attached at sn-1 position of phospholipids (phospholipase A1 activity) only if an ether linkage rather than an ester linkage is present at the sn-2 position. This hydrolysis is not stereospecific (PubMed : 7794891). Has calcium-independent phospholipase A2 and lysophospholipase activities in the presence of phosphoinositides (PubMed : 12672805). Has O-acyltransferase activity. Catalyzes the transfer of fatty acyl chains from phospholipids to a primary hydroxyl group of glycerol (sn-1 or sn-3), potentially contributing to monoacylglycerol synthesis (PubMed : 7794891).
See full target information PLA2G4A

Publications (20)

Recent publications for all applications. Explore the full list and refine your search

Nature communications 15:6252 PubMed39048572

2024

Spatially and temporally probing distinctive glycerophospholipid alterations in Alzheimer's disease mouse brain via high-resolution ion mobility-enabled sn-position resolved lipidomics.

Applications

Unspecified application

Species

Unspecified reactive species

Shuling Xu,Zhijun Zhu,Daniel G Delafield,Michael J Rigby,Gaoyuan Lu,Megan Braun,Luigi Puglielli,Lingjun Li

eNeuro 9: PubMed36351818

2022

Cyclin-Dependent Kinase 5 Regulates cPLA2 Activity and Neuroinflammation in Parkinson's Disease.

Applications

Unspecified application

Species

Unspecified reactive species

Sangita Paul,Saman Fatihi,Srishti Sharma,Rintu Kutum,Raymond Fields,Harish C Pant,Lipi Thukral,Binukumar Bk

Pharmaceutics 14: PubMed36365256

2022

Increased Expression and Activity of Brain Cortical cPLA2 Due to Chronic Lipopolysaccharide Administration in Mouse Model of Familial Alzheimer's Disease.

Applications

Unspecified application

Species

Unspecified reactive species

Mikko Gynther,Mariana Leal Estrada,Sanna Loppi,Paula Korhonen,Katja M Kanninen,Tarja Malm,Jari Koistinaho,Seppo Auriola,Gert Fricker,Elena Puris

Nature communications 13:5677 PubMed36167809

2022

Fatty acids homeostasis during fasting predicts protection from chemotherapy toxicity.

Applications

Unspecified application

Species

Unspecified reactive species

Marta Barradas,Adrián Plaza,Gonzalo Colmenarejo,Iolanda Lázaro,Luis Filipe Costa-Machado,Roberto Martín-Hernández,Victor Micó,José Luis López-Aceituno,Jesús Herranz,Cristina Pantoja,Hector Tejero,Alberto Diaz-Ruiz,Fatima Al-Shahrour,Lidia Daimiel,Viviana Loria-Kohen,Ana Ramirez de Molina,Alejo Efeyan,Manuel Serrano,Oscar J Pozo,Aleix Sala-Vila,Pablo J Fernandez-Marcos

Blood 140:2477-2489 PubMed35930749

2022

MAPK-interacting kinase 1 regulates platelet production, activation, and thrombosis.

Applications

Unspecified application

Species

Unspecified reactive species

Bhanu Kanth Manne,Robert A Campbell,Seema Bhatlekar,Abigail Ajanel,Frederik Denorme,Irina Portier,Elizabeth A Middleton,Neal D Tolley,Yasuhiro Kosaka,Emilie Montenont,Li Guo,Jesse W Rowley,Paul F Bray,Shancy Jacob,Rikiro Fukanaga,Christopher Proud,Andrew S Weyrich,Matthew T Rondina

Toxicology research 11:683-695 PubMed36051659

2022

Endoplasmic-reticulum-stress-induced lipotoxicity in human kidney epithelial cells.

Applications

Unspecified application

Species

Unspecified reactive species

Tuğçe Çeker,Çağatay Yılmaz,Esma Kırımlıoglu,Mutay Aslan

Annals of neurology 91:389-403 PubMed34979595

2022

Preserving Brain LPC-DHA by Plasma Supplementation Attenuates Brain Injury after Cardiac Arrest.

Applications

Unspecified application

Species

Unspecified reactive species

Mitsuaki Nishikimi,Muhammad Shoaib,Rishabh C Choudhary,Tomoaki Aoki,Santiago J Miyara,Tsukasa Yagi,Kei Hayashida,Ryosuke Takegawa,Tai Yin,Lance B Becker,Junhwan Kim

Journal of experimental & clinical cancer research : CR 40:344 PubMed34727953

2021

Arachidonic acid drives adaptive responses to chemotherapy-induced stress in malignant mesothelioma.

Applications

Unspecified application

Species

Unspecified reactive species

Mario Cioce,Claudia Canino,Harvey Pass,Giovanni Blandino,Sabrina Strano,Vito Michele Fazio

Scientific reports 11:6341 PubMed33737707

2021

The effects of myelin on macrophage activation are phenotypic specific via cPLA in the context of spinal cord injury inflammation.

Applications

Unspecified application

Species

Unspecified reactive species

Timothy J Kopper,Bei Zhang,William M Bailey,Kara E Bethel,John C Gensel

Clinical oral investigations 25:1933-1944 PubMed32820432

2020

Leptin reduces in vitro cementoblast mineralization and survival as well as induces PGE2 release by ERK1/2 commitment.

Applications

Unspecified application

Species

Unspecified reactive species

G Ruiz-Heiland,J W Yong,J von Bremen,S Ruf
View all publications
websiteProtocolBooklet
en

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com